Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK The Teamsters union sued Pfizer yesterday, alleging it has been defrauded into paying for Lipitor prescriptions that were written for unapproved uses that the company illegally promoted.
The suit requests class-action status, and alleges that Medicare and Medicaid also paid for prescriptions that were written “off label,” meaning for uses not approved by the federal government.
The suit’s consequences are potentially enormous—the cholesterol-fighting brand has nearly $13 billion in sales annually, making up about one-fifth of all Pfizer’s revenue.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in